NGS Streamlines Biomarker Testing in Solid Tumors Chen, PharmD, MS, BCOP, CPP, discusses how next-generation sequencing improves biomarker testing and treatment planning in solid tumors.
Switzerland to Revamp Coin Designs After 150 years of largely unchanged coin designs, Switzerland is seeking new creativity for its 10th s…
Nissan's All-Solid-State EV Batteries Nissan's big bet on all-solid-state EV batteries might just pay off. The Japanese automaker has move…
Sports Equinox: A Rare Night for Sports Fans Tonight, October 27, is a special night for sports fans, with all four major professional spo…
GSK Agrees to $357 Million Exclusive License Agreement GSK secures exclusive rights to Syndivia's promising ADC for metastatic castration-…
Jeremy Allen White Responds to Wolverine Fan Casting Jeremy Allen White, star of The Bear, has responded to fan casting as Wolverin…
How AI Improves Healthcare Collaboration and Productivity in a Hybrid Work Environment As hybrid work in healthcare evolves, artificial in…
Adalimumab Biosimilar Yuflyma Gets Approval for Additional Pediatric Indications The FDA has expanded the approval of Yuflyma (adalimumab-…
Syngene International Expands Capabilities Syngene International, a global contract research, development and manufacturing organization (…